share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Apr 4 11:15
Summary by Moomoo AI
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 40,000 Class A shares on 04/04/2024, with an aggregate market value of $360,800. The shares to be sold were acquired through stock option exercises on various dates, with the most recent being on 07/12/2023. Gibson's acquisition of these shares was through cash payments to the issuer. This planned sale follows a series of transactions over the past three months, where a total of 239,591 shares were sold for gross proceeds of approximately $2.4 million.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 40,000 Class A shares on 04/04/2024, with an aggregate market value of $360,800. The shares to be sold were acquired through stock option exercises on various dates, with the most recent being on 07/12/2023. Gibson's acquisition of these shares was through cash payments to the issuer. This planned sale follows a series of transactions over the past three months, where a total of 239,591 shares were sold for gross proceeds of approximately $2.4 million.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more